Genetic inactivation of D-amino acid oxidase enhances extinction and reversal learning in mice

  1. Viviane Labrie126,
  2. Steven Duffy1,
  3. Wei Wang3,
  4. Steven W. Barger34,
  5. Glen B. Baker5 and
  6. John C. Roder12
  1. 1Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto M5G 1X5, Canada;
  2. 2Institute of Medical Science, University of Toronto, Toronto M5S 1A8, Canada;
  3. 3Department of Neurobiology and Developmental Sciences, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA;
  4. 4Department of Geriatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA;
  5. 5Neurochemical Research Unit and Bebensee Schizophrenia Research Unit, Department of Psychiatry, University of Alberta, Edmonton T6G 2G3, Canada

    Abstract

    Activation of the N-methyl-d-aspartate receptor (NMDAR) glycine site has been shown to accelerate adaptive forms of learning that may benefit psychopathologies involving cognitive and perseverative disturbances. In this study, the effects of increasing the brain levels of the endogenous NMDAR glycine site agonist D-serine, through the genetic inactivation of its catabolic enzyme D-amino acid oxidase (DAO), were examined in behavioral tests of learning and memory. In the Morris water maze task (MWM), mice carrying the hypofunctional Dao1G181R mutation demonstrated normal acquisition of a single platform location but had substantially improved memory for a new target location in the subsequent reversal phase. Furthermore, Dao1G181R mutant animals exhibited an increased rate of extinction in the MWM that was similarly observed following pharmacological administration of D-serine (600 mg/kg) in wild-type C57BL/6J mice. In contextual and cued fear conditioning, no alterations were found in initial associative memory recall; however, extinction of the contextual fear memory was facilitated in mutant animals. Thus, an augmented level of D-serine resulting from reduced DAO activity promotes adaptive learning in response to changing conditions. The NMDAR glycine site and DAO may be promising therapeutic targets to improve cognitive flexibility and inhibitory learning in psychiatric disorders such as schizophrenia and anxiety syndromes.

    Footnotes

    | Table of Contents